Expression of Gpnmb in NK Cell Development from Hematopoietic Stem Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Molecular mechanisms of natural killer (NK) cell development from hematopoietic stem cells (HSCs) have not been clearly elucidated, although the roles of some genes in NK cell development have been reported previously. Thus, searching for molecules and genes related NK cell developmental stage is important to understand the molecular events of NK cell development. Methods: From our previous SAGE data-base, Gpnmb (Glycoprotein non-metastatic melanoma protein B) was selected for further analysis. We confirmed the level of mRNA and protein of Gpnmb through RT-PCR, quantitative PCR, and FACS analysis. Then we performed cell-based ELISA and FACS analysis, to know whether there are some molecules which can bind to Gpnmb. Using neutralizing antibody, we blocked the interaction between NK cells and OP9 cells, and checked IFN-γ production by ELISA kit. Results: Gpnmb expression was elevated during in vitro developmental stage and bound to OP9 cells, but not to NK precursor cells. In addition, we confirmed that the levels of Gpnmb were increased at NK precursor stage in vivo. We confirmed syndecan4 as a candidate of Gpnmb's binding molecule. When the interaction between NK cells and OP9 cells were inhibited in vitro, IFN-γ production from NK cells were reduced. Conclusion: Based on these observations, it is concluded that Gpnmb has a potential role in NK cell development from HSCs.
Abstract
Background: Molecular mechanisms of natural killer (NK) cell development from hematopoietic stem cells (HSCs) have not been clearly elucidated, although the roles of some genes in NK cell development have been reported previously. Thus, searching for molecules and genes related NK cell developmental stage is important to understand the molecular events of NK cell development. Methods: From our previous SAGE data-base, Gpnmb (Glycoprotein non-metastatic melanoma protein B) was selected for further analysis. We confirmed the level of mRNA and protein of Gpnmb through RT-PCR, quantitative PCR, and FACS analysis. Then we performed cell-based ELISA and FACS analysis, to know whether there are some molecules which can bind to Gpnmb. Using neutralizing antibody, we blocked the interaction between NK cells and OP9 cells, and checked IFN-γ production by ELISA kit. Results: Gpnmb expression was elevated during in vitro developmental stage and bound to OP9 cells, but not to NK precursor cells. In addition, we confirmed that the levels of Gpnmb were increased at NK precursor stage in vivo. We confirmed syndecan4 as a candidate of Gpnmb's binding molecule. When the interaction between NK cells and OP9 cells were inhibited in vitro, IFN-γ production from NK cells were reduced. Conclusion: Based on these observations, it is concluded that Gpnmb has a potential role in NK cell development from HSCs.
참고문헌 (19)
- Freud AG, "Human natural killer cell development", Immunol Rev, 214, pp.56~72 (2006)
- Mrozek E, "Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells", Blood, 87, pp.2632~2640 (1996)
- Williams NS, "Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells", J Immunol, 163, pp.2648~2656 (1999)
- Kang HS, "Stage-dependent gene expression profiles during natural killer cell development", Genomics, 86, pp.551~565 (2005)
- Rich JN, "Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model", J Biol Chem, 278, pp.15951~15957 (2003)
- Selim AA, "Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro", Crit Rev Eukaryot Gene Expr, 13, pp.265~275 (2003)
- Rose AA, "Osteoactivin", HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?, 2007, pp.9, 403~
- Ogasawara K, "Requirement for IRF-1 in the microenvironment supporting development of natural killer cells", Nature, 391, pp.700~703 (1998)
- Nakamura A, "Early induction of osteoactivin expression in rat renal tubular epithelial cells after unilateral ureteral obstruction", Exp Toxicol Pathol, 59, pp.53~59 (2007)
- Rosmaraki EE, "Identification of committed NK cell progenitors in adult murine bone marrow", Eur J Immunol, 31, pp.1900~1909 (2001)
- Roth C, "Stromalcell regulation of natural killer cell differentiation", J Mol Med, 85, pp.1047~1056 (2007)
- Chung JS, "DC-HIL is a negative regulator of T lymphocyte activation", Blood, 109, pp.4320~4327 (2007)
- Chung JS, "Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation", J Immunol, 179, pp.5778~5784 (2007)
- Vosshenrich CA, "Distinguishing features of developing natural killer cells", Curr Opin Immunol, 17, pp.151~158 (2005)
- Shikano S, "Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans", J Biol Chem, 276, pp.8125~8134 (2001)
- Bernfield M, "Functions of cell surface heparan sulfate proteoglycans", Annu Rev Biochem, 68, pp.729~777 (1999)
- Yamashita Y, "Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes", J Immunol, 162, pp.5940~5948 (1999)
- Kim S, "Licensing of natural killer cells by host major histocompatibility complex class I molecules", Nature, 436, pp.709~713 (2005)
- Samson SI, "GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells", Immunity, 19, pp.701~711 (2003)